A Review of Genomic Testing and SDH‐ Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST

Documenti analoghi

• Serum Pepsinogen as a Biomarker of Gastrointestinal Stromal Tumors (GIST) in Stomach
  di: Zhiying Gao, et al.
  Pubblicazione: (2025)
• Urokinase Plasminogen Activator Receptor‐Associated Protein ( uPARAP ) as a Potential Next Generation Molecular Target for Treatment of Gastrointestinal Stromal Tumors ( GIST )
  di: Chao‐Chi Wang, et al.
  Pubblicazione: (2026)
• NF1 Mutated Gastrointestinal Stromal Tumors With Coamplification of MDM2 and MYC
  di: Xinyang Chen, et al.
  Pubblicazione: (2025)
• A Retrospective Analysis of the Efficacy and Safety of Imatinib for Advanced Gastrointestinal Stromal Tumor in Elderly Patients
  di: Takahito Awatsu, et al.
  Pubblicazione: (2025)
• Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient—A Case Report
  di: Maud B. A. van der Kleij, et al.
  Pubblicazione: (2025)